- Home
- RLX vs RNA Comparison
RLX vs RNA Comparison
Compare RLX & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLX
- RNA
- Stock Information
- Founded
- RLX 2018
- RNA 2012
- Country
- RLX China
- RNA United States
- Employees
- RLX N/A
- RNA N/A
- Industry
- RLX Medicinal Chemicals and Botanical Products
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- RLX Health Care
- RNA Health Care
- Exchange
- RLX Nasdaq
- RNA Nasdaq
- Market Cap
- RLX 3.6B
- RNA 3.7B
- IPO Year
- RLX 2021
- RNA 2020
- Fundamental
- Price
- RLX $1.91
- RNA $31.60
- Analyst Decision
- RLX Hold
- RNA Strong Buy
- Analyst Count
- RLX 1
- RNA 12
- Target Price
- RLX $2.50
- RNA $68.25
- AVG Volume (30 Days)
- RLX 7.4M
- RNA 1.3M
- Earning Date
- RLX 03-14-2025
- RNA 05-08-2025
- Dividend Yield
- RLX 0.42%
- RNA N/A
- EPS Growth
- RLX 7.27
- RNA N/A
- EPS
- RLX 0.06
- RNA N/A
- Revenue
- RLX $334,907,454.00
- RNA $10,897,000.00
- Revenue This Year
- RLX $58.03
- RNA N/A
- Revenue Next Year
- RLX $17.11
- RNA $230.08
- P/E Ratio
- RLX $33.43
- RNA N/A
- Revenue Growth
- RLX 96.50
- RNA 13.98
- 52 Week Low
- RLX $1.50
- RNA $21.56
- 52 Week High
- RLX $2.69
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- RLX 36.99
- RNA 50.31
- Support Level
- RLX $1.91
- RNA $30.12
- Resistance Level
- RLX $2.03
- RNA $33.13
- Average True Range (ATR)
- RLX 0.11
- RNA 2.14
- MACD
- RLX -0.03
- RNA 0.14
- Stochastic Oscillator
- RLX 1.06
- RNA 35.92
About RLX RLX Technology Inc. each representing the right to receive one (1) ordinary share
RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers. It has an integrated offline distribution and "Branded store plus" retail model tailored to China's e-vapor market.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.